MCID: CCC002
MIFTS: 52

Coccidiosis

Categories: Gastrointestinal diseases, Infectious diseases

Aliases & Classifications for Coccidiosis

MalaCards integrated aliases for Coccidiosis:

Name: Coccidiosis 12 41 14 69
Intestinal Coccidiosis 12
Enteric Coccidiosis 69

Classifications:



External Ids:

Disease Ontology 12 DOID:2113
MeSH 41 D003048
NCIt 46 C34493
SNOMED-CT 64 186125004 62005008

Summaries for Coccidiosis

Disease Ontology : 12 A parasitic protozoa infectious disease that occurs in the intestinal tract of animals and humans caused by Coccidia protozoa. Immunocompromised persons are at greater risk of developing the infection.

MalaCards based summary : Coccidiosis, also known as intestinal coccidiosis, is related to cryptosporidiosis and toxoplasmosis. An important gene associated with Coccidiosis is CD40LG (CD40 Ligand), and among its related pathways/superpathways are Allograft rejection and Influenza A. The drugs Valproic Acid and Bevacizumab have been mentioned in the context of this disorder. Affiliated tissues include breast, brain and bone, and related phenotypes are hematopoietic system and liver/biliary system

Related Diseases for Coccidiosis

Diseases related to Coccidiosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 315)
# Related Disease Score Top Affiliating Genes
1 cryptosporidiosis 32.6 BFSP2 CD40LG CD79A
2 toxoplasmosis 30.9 CD40LG CD79A IFNG IL10 IL4 RHD
3 alpha chain disease 30.6 CD40LG CD79A
4 immune suppression 30.3 IFNG IL10 IL2
5 allergic hypersensitivity disease 30.1 IFNG IL10 IL4 TLR9
6 conjunctivitis 30.0 IFNG IL2 IL4
7 leishmaniasis 29.5 IFNG IL10 IL4 TLR9 TNF
8 acquired immunodeficiency syndrome 29.5 CD40LG CD79A IFNG IL10 IL2 TNF
9 malaria 28.2 CD40LG IFNG IL10 IL2 IL4 MT-CYB
10 sarcocystosis 11.2
11 coccidioidomycosis 11.2
12 cyclosporiasis 10.9
13 cystoisosporiasis 10.9
14 selective igg deficiency disease 10.7 CD40LG CD79A
15 c1q nephropathy 10.7 CD40LG CD79A
16 meningovascular neurosyphilis 10.6 CD40LG CD79A
17 brill-zinsser disease 10.6 CD40LG CD79A
18 exudative glomerulonephritis 10.6 CD40LG CD79A
19 cork-handlers' disease 10.6 CD40LG CD79A
20 salpingo-oophoritis 10.6 CD40LG CD79A
21 ross river fever 10.6 CD40LG IL10
22 early yaws 10.6 CD40LG CD79A
23 ventilation pneumonitis 10.6 CD40LG CD79A
24 chronic interstitial cystitis 10.6 CD40LG CD79A
25 axillary adenitis 10.6 CD40LG CD79A
26 cryofibrinogenemia 10.6 CD40LG CD79A
27 trichostrongyloidiasis 10.6 CD40LG CD79A
28 subacute bacterial endocarditis 10.6 CD40LG CD79A
29 heterophyiasis 10.6 CD40LG CD79A
30 immunoglobulin g deficiency 10.6 CD40LG CD79A
31 orbital granuloma 10.6 CD40LG CD79A
32 transient hypogammaglobulinemia of infancy 10.6 CD40LG CD79A
33 neuroschistosomiasis 10.6 CD79A IFNG
34 hyperglobulinemic purpura 10.6 CD40LG CD79A
35 gastroduodenitis 10.6 CD40LG CD79A
36 bacterial conjunctivitis 10.6 CD40LG CD79A
37 heavy chain disease 10.6 CD40LG CD79A
38 ophthalmia neonatorum 10.6 CD40LG CD79A
39 parotid disease 10.6 CD40LG CD79A
40 punctate inner choroidopathy 10.6 IL10 TNF
41 cerebral arteritis 10.6 CD40LG CD79A
42 optic papillitis 10.6 CD40LG MRAP
43 variola major 10.5 IFNG IL2
44 oral tuberculosis 10.5 IL2 TNF
45 selective immunoglobulin deficiency disease 10.5 CD40LG CD79A
46 eye lymphoma 10.5 IL10 TLR9
47 acute retinal necrosis syndrome 10.5 CD40LG MRAP
48 ocular toxoplasmosis 10.5 CD40LG CD79A TLR9
49 mycoplasmal pneumonia 10.5 IFNG IL4
50 autoimmune disease of urogenital tract 10.5 CD40LG CD79A TLR9

Graphical network of the top 20 diseases related to Coccidiosis:



Diseases related to Coccidiosis

Symptoms & Phenotypes for Coccidiosis

MGI Mouse Phenotypes related to Coccidiosis:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.85 IL10 IL2 IL4 RHD TLR9 TNF
2 liver/biliary system MP:0005370 9.5 IL10 IL2 IL4 TNF BAG1 CD79A
3 neoplasm MP:0002006 9.1 IFNG IL10 IL2 TNF BAG1 CD79A

Drugs & Therapeutics for Coccidiosis

Drugs for Coccidiosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 97)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Valproic Acid Approved, Investigational Phase 4 99-66-1 3121
2
Bevacizumab Approved, Investigational Phase 4 216974-75-3
3
Fluconazole Approved, Investigational Phase 4,Phase 3 86386-73-4 3365
4
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2 22916-47-8 4189
5
Levoleucovorin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 68538-85-2
6
Pyrimethamine Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 58-14-0 4993
7
Spiramycin Approved Phase 4,Phase 3,Phase 1 24916-50-5
8
Sulfadiazine Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 68-35-9 5215
9
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 59-30-3 6037
10
leucovorin Approved, Nutraceutical Phase 4,Phase 3,Phase 2,Phase 1 58-05-9 143 6006
11 Anti-Infective Agents Phase 4,Phase 3,Phase 1,Phase 2
12 Antiparasitic Agents Phase 4,Phase 3,Phase 1,Phase 2
13 Anticonvulsants Phase 4
14 Antimanic Agents Phase 4
15 Central Nervous System Depressants Phase 4
16 GABA Agents Phase 4
17 Neurotransmitter Agents Phase 4,Phase 2
18 Psychotropic Drugs Phase 4,Phase 2
19 Tranquilizing Agents Phase 4
20 Angiogenesis Inhibitors Phase 4,Phase 1,Phase 2
21 Angiogenesis Modulating Agents Phase 4,Phase 1,Phase 2
22 Antifungal Agents Phase 4,Phase 3,Phase 1,Phase 2
23 Cytochrome P-450 CYP2C9 Inhibitors Phase 4,Phase 3,Phase 1
24 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
25 Hormone Antagonists Phase 4,Phase 3
26 Hormones Phase 4,Phase 3
27 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3
28 Steroid Synthesis Inhibitors Phase 4,Phase 3
29 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1
30 Antidotes Phase 4,Phase 2,Phase 1
31 Antimalarials Phase 4,Phase 3,Phase 2,Phase 1
32 Antiprotozoal Agents Phase 4,Phase 3,Phase 1,Phase 2
33 Bone Density Conservation Agents Phase 4,Phase 1
34 Calcium, Dietary Phase 4,Phase 2,Phase 1
35 Folic Acid Antagonists Phase 4,Phase 3,Phase 2,Phase 1
36 Micronutrients Phase 4,Phase 1
37 Protective Agents Phase 4,Phase 2,Phase 1
38 Trace Elements Phase 4,Phase 1
39 Vitamin B Complex Phase 4,Phase 3,Phase 2,Phase 1
40 Vitamins Phase 4,Phase 1
41 Folate Nutraceutical Phase 4,Phase 3,Phase 2,Phase 1
42 Vitamin B9 Nutraceutical Phase 4,Phase 3,Phase 2,Phase 1
43
Nitazoxanide Approved, Investigational, Vet_approved Phase 3,Phase 1,Phase 2 55981-09-4 41684
44
Posaconazole Approved, Investigational, Vet_approved Phase 3 171228-49-2 147912
45
Clotrimazole Approved, Vet_approved Phase 3 23593-75-1 2812
46
Sulfamethoxazole Approved Phase 3 723-46-6 5329
47
Trimethoprim Approved, Vet_approved Phase 3 738-70-5 5578
48 Renal Agents Phase 3
49 Trimethoprim, Sulfamethoxazole Drug Combination Phase 3
50
Atovaquone Approved Phase 2,Phase 1 95233-18-4 74989

Interventional clinical trials:

(show top 50) (show all 59)

# Name Status NCT ID Phase Drugs
1 Pilot Trial of Valproate as Adjunctive Treatment for Toxoplasma Gondii Infection in Early Course Schizophrenia Completed NCT02011750 Phase 4 Sodium Valproate treatment;Placebo
2 Intravitreal Bevacizumab in Recalcitrant Inflammatory Ocular Neovascularization Completed NCT00645697 Phase 4
3 Early Fluconazole Treatment for Coccidiodomycosis Pneumonia Recruiting NCT02663674 Phase 4 Fluconazole
4 Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis Recruiting NCT00004317 Phase 4 Leucovorin calcium;Pyrimethamine;Spiramycin;Sulfadiazine
5 Assessment of Two Therapeutic Strategies in the Treatment of Children With Congenital Toxoplasmosis Unknown status NCT01202500 Phase 3
6 POS vs FLU for First Line Treatment of Coccidioidomycosis (Study P04558Am1)(COMPLETED) Completed NCT00423267 Phase 3 Posaconazole;Fluconazole
7 A Multi-center Study of Spherule-Derived Coccidioidin Completed NCT00690092 Phase 3
8 Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081) Completed NCT00000676 Phase 3 Clotrimazole;Fluconazole
9 Prevention of Congenital Toxoplasmosis With Pyrimethamine + Sulfadiazine Versus Spiramycine During Pregnancy Completed NCT01189448 Phase 3 Pyrimethamine/Sulfadiazine;Spiramycine
10 Influence of Trimethoprim-Sulfamethoxazole for the Recurrence of Ocular Toxoplasmosis Completed NCT01449877 Phase 3 Trimethoprim-Sulfamethoxazole
11 Safety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients Terminated NCT00004986 Phase 3 Nitazoxanide
12 Safety/Immunogenicity/Genetic Drift of MP-12 Rift Valley Fever Vaccine Completed NCT00415051 Phase 2
13 Safety and Immunogenicity Study of Rift Valley Fever Vaccine Completed NCT00584194 Phase 2
14 Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants Completed NCT00289185 Phase 2
15 Double-blind Study of Safety and Immunogenicity of Two Candidate Malaria Vaccines in Gabonese Children Completed NCT00307021 Phase 2
16 Nitazoxanide for the Treatment of Chronic Diarrhea in HIV Infected Children Completed NCT00055107 Phase 1, Phase 2 Nitazoxanide
17 A Study of Nitazoxanide in Patients With AIDS and Diarrhea Caused by Cryptosporidium Completed NCT00001081 Phase 2 Nitazoxanide
18 Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis Completed NCT00000794 Phase 2 Sulfadiazine;Clarithromycin;Atovaquone;Pyrimethamine;Leucovorin calcium
19 A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3 Completed NCT00000771 Phase 2 Paromomycin sulfate
20 Primary Prophylaxis of Cerebral Toxoplasmosis in HIV-Infected Patients Completed NCT00000643 Phase 2 Pyrimethamine;Leucovorin calcium
21 Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated Enrolling by invitation NCT00869713 Phase 2
22 Sertraline in Addition to Standard of Care Treatment for Coccidioidomycosis Not yet recruiting NCT02908334 Phase 2 Sertraline
23 A Phase 2A Evaluation of the Safety, Tolerability, Pharmacokinetics, Efficacy of Clofazimine (CFZ) in Cryptosporidiosis Not yet recruiting NCT03341767 Phase 2 Clofazimine;Placebo
24 Safety and PK of Nikkomycin Z for Coccidioides Pneumonia Treatment Terminated NCT00614666 Phase 1, Phase 2 nikkomycin Z
25 Interleukin 12 (IL-12) for the Treatment of Cryptosporidiosis in AIDS Patients Terminated NCT00057486 Phase 1, Phase 2 IL-12
26 Phase I Study of Pyrimethamine in Healthy Japanese and Caucasian Subjects Completed NCT03258762 Phase 1 Pyrimethamine;Calcium folinate
27 Antiretroviral Drug Interaction Study in Volunteers With HIV Completed NCT01479361 Phase 1 Atovaquone 750 mg twice daily;Atovaquone 1500 mg twice daily
28 A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo-Controlled Trial of the Efficacy and Safety of Bovine Anti-Cryptosporidium Immunoglobulin (BACI) in the Treatment of Cryptosporidium Enteritis in AIDS Patients Completed NCT00002248 Phase 1 Cryptosporidium Immune Whey Protein Concentrate (Bovine)
29 A Study of Letrazuril in the Treatment of AIDS-Related Diarrhea Completed NCT00001018 Phase 1 Letrazuril
30 A Study of Spiramycin in the Treatment of Patients With AIDS-Related Diarrhea Completed NCT00000980 Phase 1 Spiramycin
31 A Study of Pyrimethamine in the Treatment of Infection by a Certain Parasite in HIV-Positive Patients Completed NCT00000973 Phase 1 Pyrimethamine;Leucovorin calcium;Zidovudine
32 A Study of Azithromycin Plus Pyrimethamine in the Treatment of a Brain Infection in Patients With AIDS Completed NCT00000966 Phase 1 Azithromycin;Pyrimethamine;Leucovorin calcium
33 A Study to Evaluate the Use of Nitazoxanide to Treat Cryptosporidiosis Unknown status NCT00002158 Nitazoxanide
34 Risk of Coccidioidomycosis in Patients Receiving Anti-TNF and Other Biologic Agents for an Inflammatory Arthritis Completed NCT00796809
35 Rift Valley Fever in Kenya Completed NCT00287014
36 A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common Completed NCT00002325 Fluconazole
37 Open, Non-Comparative Study of Fluconazole in Patients With Coccidioidal Meningitis Completed NCT00002010 Fluconazole
38 Cerebral Toxoplasmosis and AIDS Completed NCT00803621
39 Evaluation of Biological Biomarkers Diagnostic of Toxoplasmosis Uveitis Completed NCT02843438 Anti-toxoplasmosis treatment;Anti-inflammatory treatments
40 Breast Milk Composition and HIV-exposed/Unexposed Early Infant Growth and Infectious Disease Events Completed NCT01699841
41 Trial of Ceramic Water Filters to Reduce Cryptosporidium Infection in Kenya Completed NCT01695304
42 Transmission and the Respiratory Tract in Cryptosporidiosis Completed NCT00507871
43 Azithromycin in the Treatment of Cryptosporidiosis in Patients Who Have Not Had Success With Other Drugs Completed NCT00002328 Azithromycin
44 A 28-Day Study of Diclazuril in the Treatment of Cryptosporidiosis in Patients With AIDS Completed NCT00002278 Diclazuril
45 The Effectiveness of Cow's Milk Immune Globulin in the Treatment of AIDS-Related Diarrhea Completed NCT00002264 Cryptosporidium Immune Whey Protein Concentrate (Bovine)
46 Azithromycin in the Treatment of Cryptosporidiosis in Patients With Acquired Immune Deficiency Syndrome (AIDS): A Randomized, Multi-Center, Placebo-Controlled, Double-Blind Study Completed NCT00002082 Azithromycin
47 Toxoplasmic Encephalitis in Patients With AIDS. Treatment and Prevention of Relapse Completed NCT00002064 Pyrimethamine;Clindamycin
48 Open-Label "Compassionate" Use Study of Spiramycin for the Treatment of Diarrhea Due to Chronic Cryptosporidiosis in Immunocompromised Patients Completed NCT00002062 Spiramycin
49 Protocol For the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433) Completed NCT00002027 Diclazuril
50 A Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus (HIV) Who Have Failed or Are Intolerant of Pyrimethamine-Sulfadiazine Completed NCT00001994 Atovaquone

Search NIH Clinical Center for Coccidiosis

Cochrane evidence based reviews: coccidiosis

Genetic Tests for Coccidiosis

Anatomical Context for Coccidiosis

MalaCards organs/tissues related to Coccidiosis:

38
Breast, Brain, Bone, T Cells, Liver, Small Intestine, Testes

Publications for Coccidiosis

Articles related to Coccidiosis:

(show top 50) (show all 573)
# Title Authors Year
1
Coccidiosis in Large and Small Ruminants. ( 29249601 )
2018
2
Evaluation of amprolium and toltrazuril efficacy in controlling natural intestinal rabbit coccidiosis. ( 29163644 )
2017
3
Coccidiosis of domestic pigeons (Columba livia domestica Gmelin, 1789) in Kano State, Nigeria ( 29274213 )
2017
4
EXTENSION OF THE KNOWN HOST RANGE OF INTRANUCLEAR COCCIDIOSIS: INFECTION IN THREE CAPTIVE RED-FOOTED TORTOISES ( CHELONOIDIS CARBONARIA). ( 29297806 )
2017
5
Coccidiosis in European rabbit (Oryctolagus cuniculus algirus) populations in the Iberian Peninsula. ( 28030335 )
2017
6
Coccidiosis control. ( 28550233 )
2017
7
Effects of feeding Original XPCa8c to broilers with a live coccidiosis vaccine under industrial conditions: Part 2. Cecal microbiota analysis. ( 28339832 )
2017
8
Pathology in Practice. Severe intestinal coccidiosis in a chicken. ( 28671500 )
2017
9
Treatment against coccidiosis in Norwegian lambs and potential risk factors for development of anticoccidial resistance-a questionnaire-based study. ( 28190155 )
2017
10
Inclusion of Bacillus amyloliquefaciens strain TOA5001 in the diet of broilers suppresses the symptoms of coccidiosis by modulating intestinal microbiota. ( 29282825 )
2017
11
Epicellular coccidiosis in goldfish. ( 28627487 )
2017
12
Potential Vaccine Targets against Rabbit Coccidiosis by Immunoproteomic Analysis. ( 28285502 )
2017
13
DETECTION OF INTRANUCLEAR COCCIDIOSIS IN TORTOISES IN EUROPE AND CHINA. ( 28749291 )
2017
14
Effects of feeding Original XPCa8c to broilers with a live coccidiosis-vaccine under industry conditions: Part 1. Growth performance and Salmonella inhibition. ( 28340000 )
2017
15
Effects of coccidiosis vaccination administered by in ovo injection on Ross 708 broiler performance through 14 days of post-hatch age. ( 28339834 )
2017
16
Investigations on the Occurrence and Associated Risk Factors of Avian Coccidiosis in Osun State, Southwestern Nigeria. ( 29138693 )
2017
17
Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery against Malaria, Leishmaniasis, Toxoplasmosis, Cryptosporidiosis, and Coccidiosis. ( 28867614 )
2017
18
Simple and noninvasive method for assessment of digestive efficiency: Validation of fecal steatocrit in greenfinch coccidiosis model. ( 28035266 )
2016
19
Prevalence of coccidiosis among village and exotic breed of chickens in Maiduguri, Nigeria. ( 27397991 )
2016
20
Herbal Remedies for Coccidiosis Control: A Review of Plants, Compounds, and Anticoccidial Actions. ( 27429634 )
2016
21
Coccidiosis in European rabbit (Oryctolagus cuniculus algirus) populations in the Iberian Peninsula. ( 27447236 )
2016
22
Beneficial Effect of Bidens pilosa on Body Weight Gain, Food Conversion Ratio, Gut Bacteria and Coccidiosis in Chickens. ( 26765226 )
2016
23
Evaluation of furazolidone, sulfadimidine and amprolium to treat coccidiosis in beetal goats under field conditions. ( 27087093 )
2016
24
Susceptibility of Broiler Chickens to Coccidiosis When Fed Subclinical Doses of Deoxynivalenol and Fumonisins-Special Emphasis on the Immunological Response and the Mycotoxin Interaction. ( 27472362 )
2016
25
Anticoccidial effect of mananoligosacharide against experimentally induced coccidiosis in broiler. ( 27068898 )
2016
26
Three operational taxonomic units of Eimeria are common in Nigerian chickens and may undermine effective molecular diagnosis of coccidiosis. ( 27259544 )
2016
27
Immune protection duration and efficacy stability of DNA vaccine encoding Eimeria tenella TA4 and chicken IL-2 against coccidiosis. ( 27914219 )
2016
28
Prevention of coccidiosis in dairya8^cows. ( 27084611 )
2016
29
Prevention of coccidiosis in dairya8^cows. ( 27084612 )
2016
30
Prevalence of Coccidiosis in Free-Range Chicken in Sidi Thabet, Tunisia. ( 27213084 )
2016
31
Anticoccidial effect of Piper sarmentosum extracts in experimental coccidiosis in broiler chickens. ( 26984597 )
2016
32
Dynamic Patterns of Systemic Innate Immunity and Inflammatory Associated Factors in Experimental Caprine Coccidiosis. ( 28095656 )
2016
33
Study on impression smears of hepatic coccidiosis in rabbits. ( 27605807 )
2016
34
Liver mitochondrial oxygen consumption and proton leak kinetics in broilers supplemented with dietary copper or zinc following coccidiosis challenge. ( 27544066 )
2016
35
Combination of probiotics and coccidiosis vaccine enhances protection against an Eimeria challenge. ( 27825377 )
2016
36
Synergistic approach for treatment of chicken coccidiosis using berberine - A plant natural product. ( 26802524 )
2016
37
The epizootiology of Eimeria infections in commercial broiler chickens where anticoccidial drug programs were employed in six successive flocks to control coccidiosis. ( 27053624 )
2016
38
Disease surveillance of Atlantic herring: molecular characterization of hepatic coccidiosis and a morphological report of a novel intestinal coccidian. ( 27409233 )
2016
39
Effects of coccidiosis vaccination administered by in ovo injection on the hatchability and hatching chick quality of broilers. ( 27794546 )
2016
40
The effect of sainfoin (Onobrychis viciifolia) and carob pods (Ceratonia siliqua) feeding regimes on the control of lamb coccidiosis. ( 26920568 )
2016
41
Coccidiosis in the Chukar Partridge ( Alectoris chukar ): A Survey of Coccidiosis Outbreaks and a Test of Anticoccidial Drugs Against Eimeria kofoidi. ( 27902917 )
2016
42
Assessment of risk factors associated with prevalence of coccidiosis in dairy animals of Punjab. ( 27876948 )
2016
43
Field Evaluation of the Effectiveness of an Oral Toltrazuril and Iron Combination (BaycoxAr Iron) in Maintaining Weaning Weight by Preventing Coccidiosis and Anaemia in Neonatal Piglets. ( 26152420 )
2015
44
Intestinal coccidiosis of anadromous and landlocked alewives, Alosa pseudoharengus, caused by Goussia ameliae n. sp. and G. alosii n. sp. (Apicomplexa: Eimeriidae). ( 25853050 )
2015
45
Short communication: Glucagon-like peptide-2 and coccidiosis alter tight junction gene expression in the gastrointestinal tract of dairy calves. ( 25726101 )
2015
46
Gastrointestinal parasitic infections in chickens of upper gangetic plains of India with special reference to poultry coccidiosis. ( 25698854 )
2015
47
Carotenoid-enriched transgenic corn delivers bioavailable carotenoids to poultry and protects them against coccidiosis. ( 25846059 )
2015
48
Impact of coccidiosis control program and feeding plan on white striping prevalence and severity degree on broiler breast fillets evaluated at three growing ages. ( 26217032 )
2015
49
Pharmacokinetics and oral bioavailability of amoxicillin in chicken infected with caecal coccidiosis. ( 25623275 )
2015
50
Prevalence of poultry coccidiosis in Jammu region of Jammu & Kashmir State. ( 25698867 )
2015

Variations for Coccidiosis

Expression for Coccidiosis

Search GEO for disease gene expression data for Coccidiosis.

Pathways for Coccidiosis

Pathways related to Coccidiosis according to GeneCards Suite gene sharing:

(show all 40)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
12.82 CD40LG IFNG IL10 IL2 IL4 TNF
2
Show member pathways
12.76 IFNG IL2 IL4 TLR9 TNF
3
Show member pathways
12.58 CD40LG CD79A IFNG IL10 IL2 IL4
4
Show member pathways
12.56 IFNG IL10 IL2 IL4 TNF
5
Show member pathways
12.5 IFNG IL10 IL2 TLR9 TNF
6
Show member pathways
12.46 IFNG IL2 IL4 TNF
7
Show member pathways
12.44 CD40LG IFNG IL10 IL2 IL4 TNF
8
Show member pathways
12.33 IFNG IL10 IL2 IL4
9
Show member pathways
12.3 IFNG IL2 IL4 TNF
10
Show member pathways
12.26 CD40LG IFNG IL10 IL4 TNF
11 12.2 IFNG IL10 TLR9 TNF
12
Show member pathways
12.17 IFNG IL10 IL2 IL4 TNF
13
Show member pathways
12.15 IFNG IL4 TLR9 TNF
14 12.07 CD40LG CD79A IFNG IL10 IL2 IL4
15 11.99 IFNG IL2 IL4 TNF
16
Show member pathways
11.93 IFNG IL10 IL2 TLR9 TNF
17 11.84 IFNG IL10 TNF
18
Show member pathways
11.81 IFNG IL4 TLR9
19 11.76 IFNG IL2 IL4
20 11.73 IFNG IL10 IL2 IL4 TNF
21 11.7 CD79A IFNG IL10 IL2 IL4 TNF
22
Show member pathways
11.68 CD40LG IFNG IL2 TNF
23
Show member pathways
11.68 CD40LG IFNG IL2 IL4 TNF
24 11.64 IFNG IL10 IL2 TLR9 TNF
25 11.63 CD40LG IL10 IL4
26
Show member pathways
11.62 IFNG IL2 TNF
27 11.54 CD40LG IL10 IL4 TLR9 TNF
28 11.53 IFNG IL2 TNF
29 11.53 IFNG IL10 IL2 IL4
30 11.5 IL10 IL4 TNF
31 11.49 IFNG IL2 TNF
32
Show member pathways
11.39 IFNG IL10 IL2 TNF
33 11.37 IFNG IL10 TLR9 TNF
34 11.34 CD40LG IFNG IL10 TLR9 TNF
35 11.31 CD40LG IFNG IL2 IL4
36 11.29 IFNG IL4 TNF
37 11.21 CD40LG IL10 IL2 IL4 TNF
38 11.17 IFNG IL10 IL2 IL4
39 10.97 CD40LG IL10 IL2 IL4 TNF
40 10.5 IFNG IL10 IL2 IL4 TNF

GO Terms for Coccidiosis

Biological processes related to Coccidiosis according to GeneCards Suite gene sharing:

(show all 26)
# Name GO ID Score Top Affiliating Genes
1 defense response to bacterium GO:0042742 9.88 IL10 LEAP2 TLR9 TNF
2 positive regulation of T cell proliferation GO:0042102 9.73 CD40LG IL2 IL4
3 immune response GO:0006955 9.73 CD40LG IFNG IL10 IL2 IL4 TNF
4 positive regulation of B cell proliferation GO:0030890 9.65 IL2 IL4 TLR9
5 positive regulation of membrane protein ectodomain proteolysis GO:0051044 9.63 IFNG TNF
6 negative regulation of growth of symbiont in host GO:0044130 9.62 IL10 TNF
7 regulation of regulatory T cell differentiation GO:0045589 9.62 IFNG IL2
8 response to molecule of bacterial origin GO:0002237 9.61 IL10 TLR9
9 positive regulation of heterotypic cell-cell adhesion GO:0034116 9.61 IL10 TNF
10 positive regulation of isotype switching to IgG isotypes GO:0048304 9.59 IL2 IL4
11 endothelial cell apoptotic process GO:0072577 9.58 IL10 TNF
12 B cell proliferation GO:0042100 9.58 CD40LG CD79A IL10
13 positive regulation of MHC class II biosynthetic process GO:0045348 9.57 IL10 IL4
14 negative regulation of cytokine secretion involved in immune response GO:0002740 9.55 IL10 TNF
15 type 2 immune response GO:0042092 9.54 IL10 IL4
16 negative regulation of interleukin-8 production GO:0032717 9.52 IL10 TLR9
17 regulation of immunoglobulin secretion GO:0051023 9.51 CD40LG TNF
18 negative regulation of interleukin-6 production GO:0032715 9.5 IL10 TLR9 TNF
19 regulation of isotype switching GO:0045191 9.49 IL10 IL4
20 receptor biosynthetic process GO:0032800 9.46 IL10 TNF
21 positive regulation of calcidiol 1-monooxygenase activity GO:0060559 9.43 IFNG TNF
22 regulation of receptor activity GO:0010469 9.43 CD40LG IFNG IL10 IL2 IL4 TNF
23 positive regulation of vitamin D biosynthetic process GO:0060557 9.37 IFNG TNF
24 positive regulation of interleukin-12 production GO:0032735 9.33 CD40LG IFNG TLR9
25 B cell differentiation GO:0030183 8.92 CD40LG CD79A IL10 IL4
26 negative regulation of apoptotic process GO:0043066 10 BAG1 CD40LG IL10 IL2 IL4

Molecular functions related to Coccidiosis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 9.1 CD40LG IFNG IL10 IL2 IL4 TNF

Sources for Coccidiosis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....